| Sex differences in the cardiovascular consequences of diabetes mellitus: a scientific statement from the American Heart Association JG Regensteiner, S Golden, AG Huebschmann, E Barrett-Connor, ... Circulation 132 (25), 2424-2447, 2015 | 285 | 2015 |
| Associations among androgens, estrogens, and natriuretic peptides in young women: observations from the Dallas Heart Study AY Chang, SM Abdullah, T Jain, HG Stanek, SR Das, DK McGuire, ... Journal of the American College of Cardiology 49 (1), 109-116, 2007 | 219 | 2007 |
| Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study I Bancos, AE Taylor, V Chortis, AJ Sitch, C Jenkinson, CJ Davidge-Pitts, ... The lancet Diabetes & endocrinology 8 (9), 773-781, 2020 | 146 | 2020 |
| Higher natriuretic peptide levels associate with a favorable adipose tissue distribution profile IJ Neeland, BR Winders, CR Ayers, SR Das, AY Chang, JD Berry, ... Journal of the American College of Cardiology 62 (8), 752-760, 2013 | 137 | 2013 |
| Trends in thyroid cancer demographics and surgical therapy in the United States I Mitchell, EH Livingston, AY Chang, S Holt, WH Snyder III, I Lingvay, ... Surgery 142 (6), 823-828. e1, 2007 | 126 | 2007 |
| “Subclinical Cushing’s syndrome” is not subclinical: improvement after adrenalectomy in 9 patients IC Mitchell, RJ Auchus, K Juneja, AY Chang, SA Holt, WH Snyder III, ... Surgery 142 (6), 900-905. e1, 2007 | 103 | 2007 |
| Cardiotoxicity in signal transduction therapeutics: erbB2 antibodies and the heart JW Schneider, AY Chang, TP Rocco Seminars in oncology 28, 18-26, 2001 | 96 | 2001 |
| Abiraterone acetate to lower androgens in women with classic 21-hydroxylase deficiency RJ Auchus, EO Buschur, AY Chang, GD Hammer, C Ramm, D Madrigal, ... The Journal of Clinical Endocrinology & Metabolism 99 (8), 2763-2770, 2014 | 88 | 2014 |
| Trastuzumab cardiotoxicity: Speculations regarding pathophysiology and targets for further study JW Schneider, AY Chang, A Garratt Seminars in oncology 29 (3), 22-28, 2002 | 83 | 2002 |
| Polycystic ovarian syndrome and subclinical atherosclerosis among women of reproductive age in the Dallas heart study AY Chang, C Ayers, A Minhajuddin, T Jain, P Nurenberg, JA De Lemos, ... Clinical endocrinology 74 (1), 89-96, 2011 | 68 | 2011 |
| Molecular cloning of a glibenclamide-sensitive, voltage-gated potassium channel expressed in rabbit kidney. X Yao, AY Chang, EL Boulpaep, AS Segal, GV Desir The Journal of clinical investigation 97 (11), 2525-2533, 1996 | 65 | 1996 |
| Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome AY Chang, AZ Lalia, GD Jenkins, T Dutta, RE Carter, RJ Singh, KS Nair Metabolism 71, 52-63, 2017 | 62 | 2017 |
| 46, XX DSD: the masculinised female RJ Auchus, AY Chang Best Practice & Research Clinical Endocrinology & Metabolism 24 (2), 219-242, 2010 | 52 | 2010 |
| Cardiovascular risk factors and coronary atherosclerosis in retired National Football League players AY Chang, SJ FitzGerald, J Cannaday, S Zhang, A Patel, MD Palmer, ... The American journal of cardiology 104 (6), 805-811, 2009 | 47 | 2009 |
| Effect of metformin on microvascular endothelial function in polycystic ovary syndrome B Heidari, A Lerman, AZ Lalia, LO Lerman, AY Chang Mayo Clinic Proceedings 94 (12), 2455-2466, 2019 | 46 | 2019 |
| Influence of race/ethnicity on cardiovascular risk factors in polycystic ovary syndrome, the Dallas Heart Study AY Chang, J Oshiro, C Ayers, RJ Auchus Clinical endocrinology 85 (1), 92-99, 2016 | 45 | 2016 |
| Metabolic concomitants of obese and nonobese women with features of polycystic ovarian syndrome JM Boumosleh, SM Grundy, J Phan, IJ Neeland, A Chang, GL Vega Journal of the Endocrine Society 1 (12), 1417-1427, 2017 | 32 | 2017 |
| Hyperthyroidism-associated coronary vasospasm with myocardial infarction and subsequent euthyroid angina R Patel, G Peterson, A Rohatgi, HK Ghayee, EC Keeley, RJ Auchus, ... Thyroid 18 (2), 273-276, 2008 | 30 | 2008 |
| A phase 2, multicenter study of nevanimibe for the treatment of congenital adrenal hyperplasia D El-Maouche, DP Merke, MG Vogiatzi, AY Chang, AF Turcu, EG Joyal, ... The Journal of Clinical Endocrinology & Metabolism 105 (8), 2771-2778, 2020 | 29 | 2020 |
| Radiosurgical management of patients with persistent or recurrent Cushing disease after prior transsphenoidal surgery: a management algorithm based on a 25-year experience JD Hughes, WF Young Jr, AY Chang, MJ Link, YI Garces, NN Laack, ... Neurosurgery 86 (4), 557-564, 2020 | 24 | 2020 |
